Market revenue in 2023 | USD 272.4 million |
Market revenue in 2030 | USD 392.7 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Transvenous implantable cardioverter-defibrillators |
Fastest growing segment | Subcutaneous Implantable Cardioverter Defibrillators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Transvenous Implantable Cardioverter-Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, BIOTRONIK, Boston Scientific Corp, MicroPort Scientific Corp, LivaNova PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to implantable cardioverter defibrillators market will help companies and investors design strategic landscapes.
Transvenous implantable cardioverter-defibrillators was the largest segment with a revenue share of 90.05% in 2023. Horizon Databook has segmented the Latin America implantable cardioverter defibrillators market based on transvenous implantable cardioverter-defibrillators, subcutaneous implantable cardioverter defibrillators covering the revenue growth of each sub-segment from 2018 to 2030.
A study published in the European Heart Journal in August 2022 provided insights into the incidence and mortality rates of CVD across various countries in Latin America. The study revealed variations in the incidence and mortality rates, with different countries experiencing different levels of CVD burden.
Brazil had the highest incidence of CVD (3.86 per 1000 person-years), indicating a significant disease prevalence. On the other hand, Argentina had the lowest incidence (3.07 per 1000 person-years). Regarding mortality rates, Argentina had the highest rate (5.98 per 1000 person-years), while Chile had the lowest rate (4.07 per 1000 person-years).
Furthermore, the study highlighted that men had a higher incidence and mortality rate of CVD than women. Men had an incidence rate of 4.48 per 1000 person-years and a mortality rate of 6.33 per 1000 person-years, whereas women had an incidence rate of 2.60 per 1000 person-years and a mortality rate of 3.96 per 1000 person-years.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America implantable cardioverter defibrillators market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America implantable cardioverter defibrillators market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account